According to @DowdEdward, PFE’s revenue decline stems from a one-time COVID mRNA windfall tied to mandates, collapsing booster uptake, and negative word-of-mouth about side effects, creating sustained demand headwinds for the company’s vaccine franchise. Source: @DowdEdward on X (Dec 17, 2025). He adds that continued COVID infections despite vaccination undermined a booster-for-life model, which he argues pressures PFE’s top line and trader sentiment, framing a bearish near-term narrative for the stock. Source: @DowdEdward on X (Dec 17, 2025). The source does not cite any direct cryptocurrency market impact related to this view. Source: @DowdEdward on X (Dec 17, 2025).

According to @DowdEdward, Paul Offit told viewers he had not been invited to speak at an ACIP meeting occurring in Atlanta that day, and Dowd alleges this claim was false. Source: Edward Dowd on X (Dec 10, 2025). Verification should rely on the CDC’s ACIP official agenda and minutes, which publicly list invited speakers and topics and can confirm whether an invitation was issued. Source: CDC ACIP official publications. For trading, focus on vaccine-exposed equities including Pfizer (PFE), Moderna (MRNA), and Novavax (NVAX) for potential headline-driven volatility while awaiting any official CDC update; the post itself presents no primary documentation. Source: Company investor relations and product disclosures; CDC ACIP updates. If headlines escalate, broader risk sentiment could spill into crypto given the post-2020 rise in equity–crypto correlation. Source: International Monetary Fund analysis on crypto–stock correlation (2022).

According to @DowdEdward, former CDC Director Dr. Robert Redfield said he would like mRNA vaccine use curtailed and personally eliminated due to too many unknowns in an EpochTV American Thought Leaders interview scheduled for Dec. 9, 2025, highlighting potential headline risk for health-care and biotech equities; source: @DowdEdward; The Epoch Times. The comments pertain to mRNA COVID-19 products, including Pfizer-BioNTech’s Comirnaty (PFE, BNTX) and Moderna’s Spikevax (MRNA), which the U.S. FDA identifies as mRNA vaccines; source: U.S. Food and Drug Administration. Event-driven headlines of this type are typically monitored by options traders for potential implied-volatility repricing and gap risk in MRNA, PFE, BNTX and NVAX around the broadcast window; source: Cboe Options Institute. Because spot crypto trades continuously, cross-asset sentiment from major health-policy headlines can be reflected in BTC and ETH liquidity during off-hours, so crypto desks may track the interview’s release for any risk-on/off spillover; source: Coinbase Exchange.

According to @business, Novo Nordisk's Mike Doustdar lost a $10 billion takeover battle for obesity drug developer Metsera to Pfizer (PFE) (source: @business). According to @business, he is keeping deals on the table as the Danish company seeks to regain lost ground in the weight-loss boom (source: @business). According to @business, the report makes no mention of cryptocurrencies or digital assets and states no direct crypto-market linkage (source: @business).

According to @FoxNews, Pfizer has secured a $10 billion deal to acquire Metsera, ending a bidding war with Novo Nordisk and giving Pfizer a new foothold in the obesity-drug market, a headline relevant for traders focused on large-cap pharma and weight-loss treatment exposure (source: Fox News tweet; Fox Business report). The report did not cite any direct impact on cryptocurrency markets (source: Fox News tweet; Fox Business report).

According to @KobeissiLetter, Pfizer (PFE) and Moderna (MRNA) shares fell sharply on reports that US officials are planning to link COVID-19 vaccines to 25 child deaths, prompting a headline-driven selloff in biotech stocks. source: @KobeissiLetter. According to @KobeissiLetter, the post cites the report as the catalyst but does not provide price magnitude, an official statement, or document links, underscoring that the move is headline-led at this time. source: @KobeissiLetter. According to @KobeissiLetter, no direct cryptocurrency impact was mentioned; crypto traders may note the headline while monitoring broader risk sentiment for potential cross-asset effects. source: @KobeissiLetter.

According to The Kobeissi Letter, Pfizer (PFE) and Moderna (MRNA) shares fell sharply on reports that US officials are planning to link COVID-19 vaccines to 25 child deaths, source: The Kobeissi Letter on X, Sep 12, 2025. The cited post does not name the agency or provide documentation, and it includes no official confirmation, source: The Kobeissi Letter on X, Sep 12, 2025. For trading, this headline creates elevated headline risk in PFE and MRNA until an official statement is available, and market participants may prioritize liquidity monitoring and risk controls; the cited source provides no timing for any announcement, source: The Kobeissi Letter on X, Sep 12, 2025. No crypto market reaction is mentioned in the source; any impact on BTC and ETH via cross-asset risk sentiment is not referenced in the cited post, source: The Kobeissi Letter on X, Sep 12, 2025.